Home/Filings/4/0001209191-22-004194
4//SEC Filing

Deignan Charles A. 4

Accession 0001209191-22-004194

CIK 0001539029other

Filed

Jan 19, 7:00 PM ET

Accepted

Jan 20, 7:07 PM ET

Size

10.1 KB

Accession

0001209191-22-004194

Insider Transaction Report

Form 4
Period: 2022-01-18
Deignan Charles A.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2022-01-18+43,750360,199 total
  • Sale

    Common Stock

    2022-01-19$2.09/sh8,833$18,461351,366 total
  • Award

    Stock Option (Right to Buy)

    2022-01-18+131,250131,250 total
    Exercise: $2.19Exp: 2032-01-18Common Stock (131,250 underlying)
Footnotes (4)
  • [F1]These shares are represented by restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock of the Issuer. The shares underlying the RSU vest in 4 equal annual installments on each of January 18, 2023, January 18, 2024, January 18, 2025 and January 18, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
  • [F2]The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.0902 to $2.91 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]One-fourth of the shares underlying this option vest on January 18, 2023 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.

Issuer

Clearside Biomedical, Inc.

CIK 0001539029

Entity typeother

Related Parties

1
  • filerCIK 0001664690

Filing Metadata

Form type
4
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 7:07 PM ET
Size
10.1 KB